Turkish immigrant Oguzhan Atay started the company in 2016 with a focus on prenatal testing. Now, he’s expanding to cancer tests.
BillionToOne’s shares soared on its first day of trading, giving the company a market cap of $5.8 billion.a Turkish immigrant with a Ph.D. in systems biology from Stanford University, started BillionToOne in 2016 with the idea of creating noninvasive prenatal genetic tests for common diseases, like sickle cell anemia and cystic fibrosis.
Today, the Menlo Park, California-based company went public on the Nasdaq stock exchange,in an offering that was upsized to meet investor demand. By the end of trading, its shares were up more than 80%, at $109 from the offering price of $60, giving it a market cap of $5.8 billion. That makes BilliontoOne the rare medical diagnostics company to have a successful IPO this year, even more unusual given the federal government shutdown. But BillionToOne, which started with prenatal blood tests and expanded to cancer testing, has built a significant, fast-growing business. It booked from 508,000 genetic tests, according to its offering document. That compares with last year’s revenue of $153 million, itself up 19-fold from $8 million in 2021. While the company is losing money, those losses have been shrinking, to just $4 million in the first half of 2025. At a price of $109 a share, Atay’s stake in the business would be worth $335 million. His cofounder, David Tsao, the company’s chief technology officer, holds a roughly similar stake, worth nearly $325 million. “We have blown past every projection we had at the time,” Atay, the company’s cofounder and CEO, told“We are not trying to change the market or convince Congress to change reimbursement. We are taking risk on the technical , to do something that is not just 5% better.”Its patented technology can detect a single DNA letter of a single DNA molecule out of a total of 3 billion in a human genome —helping it determine if a developing baby was at risk of serious disease from one maternal blood sample. Blood tests are far less invasive than traditional tests like amniocentesis in which doctors draw amniotic fluid to test for genetic disorders. Atay, 37, and Tsao, 36, started with two common genetic blood disorders: sickle cell and beta-thalassemia. In 2023, they expanded into cancer testing, beginning with tests for people who already have cancer. BillionToOne is continuing to work on new diagnostic products in oncology, including those that could be used in early detection of cancer, one of the holy grails of testing. Still, diagnostics is a hard and capital-intensive area, and big testing companies like $27 billion Natera have been around for decades. “In the beginning it was very difficult,” Atay said, noting that BillionToOne was not only unknown to doctors, but was also out-of-network for insurers. “We were outspent and outnumbered in every region we were in,” he said. To acquire customers during the Covid-19 pandemic, he scheduled meetings with physicians in their parking lots, bringing masks that he had special-ordered from overseas with him. Today, BillionToOne is in-network with 70% of insurers, Atay said. “He’s humble, but he’s a beast,” said Shahram Seyedin-Noor, managing partner of Civilization Ventures, a healthcare-focused investment firm that was one of BillionToOne’s first investors.BillionToOne raised its first $15 million in March 2019. It has since raised nearly $375 million from investors that include Norwest and Baillie Gifford. The company did not need the capital from today’s public offering, but chose to go public to bring on institutional investors, Atay said. Today, BillionToOne projects in its offering document that the market for its existing genetic tests is worth more than $20 billion, while its pipeline of products in development could increase that to $100 billion. While prenatal tests are a big deal, early detection of cancer could be even larger. “That’s where a lot of the excitement for our company lies,” Atay said.
Prenatal Testing Genetic Testing Cancer Detection Oguzhan Atay Diagnostics Startups Billiontoone IPO Immigrant Founder Turkish Founder $BLLN
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Illegal immigrant trucker accused of causing fatal California crash pleads not guiltyToday's Video Headlines: 11/04/25
Read more »
'Led by an immigrant': NYC Mayor-elect Zohran Mamdani calls out Trump in victory speechAddressing President Donald Trump by name in his victory speech Tuesday night, Mamdani said, 'Donald Trump, since I know you're watching -- I have four words for you: Turn the volume up.'
Read more »
The DOJ has been firing judges with immigrant defense backgroundsNPR's data analysis shows that the DOJ has tended to fire judges with immigrant defense backgrounds in its recent rounds of dismissals.
Read more »
Outrage erupts after boozed-up illegal immigrant allegedly mows down blue state coupleFox News Channel offers its audiences in-depth news reporting, along with opinion and analysis encompassing the principles of free people, free markets and diversity of thought, as an alternative to the left-of-center offerings of the news marketplace.
Read more »
Immigrant gets time served after Wisconsin judge allegedly helped him dodge agentsAn immigrant who was arrested after a Milwaukee judge allegedly helped him dodge federal agents has been sentenced to time served for illegally reentering the United States. U.S. District Judge Pamela Pepper sentenced 31-year-old Eduardo Flores-Ruiz to time served after he reached a deal with prosecutors in which he agreed not to fight deportation.
Read more »
Immigrant sentenced to time served after Wisconsin judge allegedly helped him evade federal agentsMADISON, Wis. (AP) — An immigrant who was arrested after a judge in Wisconsin allegedly helped him dodge federal agents has been sentenced to time served for
Read more »